Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Ethics Forum: Mitigation Tips for Health Disparities Among Rural & Indigenous Peoples

Laura Nichols, MD, Lee Graham, MD, & Erdal Diri, MD  |  Issue: October 2023  |  October 12, 2023

A common case scenario in our practice in North Dakota is a woman with rheumatoid arthritis on methotrexate monotherapy. She is a member of the Sisseton Wahpeton Oyate people and lives 90 miles from our rheumatology clinic. She currently has moderate disease activity, indicating the need for additional treatment. She does not have her own vehicle, but a family member has generally been able to drive her to appointments at six-month intervals. Increasing the frequency of appointments is likely to be challenging. She does have a cellular telephone, but does not have access to fixed broadband service in her home.

This scenario illustrates several challenges in the provision of effective and equitable rheumatologic care for our patients, including the rural location, transportation limitations and healthcare inequity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As rheumatologists, we have an ethical obligation to address the barriers that exist to equitable care for our patients. In the next few paragraphs, we outline current challenges to care for rural and Indigenous peoples and discuss strategies to address these barriers.

Rural Health Challenges

Access to healthcare in rural areas is progressively contracting. As of early 2023, 124 rural hospitals had closed their doors over the past 17 years and an additional 425 rural hospitals are financially vulnerable, based on a 2020 report by the Chartis Group.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In rheumatology, projections estimate a shortage of 4,100 rheumatologists, with demand exceeding supply by 102% in 2030, and disproportionate effects expected in rural areas.2

Patients in rural areas face the challenges of increased travel time and associated costs, including time away from work to attend appointments. Additionally, rural patients are more likely to be managed by a non-rheumatologist, with associated diagnosis delays and higher use of corticosteroids.3

Although efforts are ongoing to improve access to technology, such as broadband internet, the digital divide remains a significant barrier for telemedicine services in rural areas.4 Rural populations tend to be older, and the lower technological literacy associated with that population can further exacerbate this digital divide.

Indigenous Patients

The Centers for Disease Control and Prevention (CDC) defines health disparities as “preventable differences in the burden of disease, injury, violence, or opportunities to achieve optimal health that are experienced by socially disadvantaged populations.”5

For American Indian and Alaska Native (AI/AN) patients, not only are there issues with transportation and broadband access, but also systemic disparities in diagnosis and manifestations of rheumatoid arthritis. Many AI/AN patients, such as the Cree/Ojibwe, Pima and Chippewa people, have a prevalence of rheumatoid arthritis at around 2–3%, near the highest prevalence worldwide, and linked to the prevalence of HLA-DRB1*1402.6 Other tribes have increased prevalence of HLA-B27 and associated spondyloarthropathies.7 Studies have shown that AI/AN patients not only present with severe RA, but also carry multiple poor outcome risk factors.6

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:EthicsGuidancePractice Support Tagged with:DisparitiesEthics Forumhealth disparitiesrural rheumatologytelemedicine

Related Articles

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Some Telemedicine Barriers Are Down During COVID-19 Pandemic

    May 15, 2020

    Telerheumatology—which refers to the application of electronic communication technology to clinical encounters from a distance between rheumatologists and their patients—has the potential to extend a workforce projected to experience significant shortfalls, making it more accessible to more patients. Multiple barriers that stood in the way of taking full advantage of this promise are now down—at…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences